Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease.

Hussain RM, Neiweem AE, Kansara V, Harris A, Ciulla TA.

Expert Opin Investig Drugs. 2019 Oct;28(10):861-869. doi: 10.1080/13543784.2019.1667333. Epub 2019 Sep 26. Review.

PMID:
31513439
2.

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes.

Ciulla TA, Hussain RM, Pollack JS, Williams DF.

Ophthalmol Retina. 2019 May 25. pii: S2468-6530(19)30280-5. doi: 10.1016/j.oret.2019.05.017. [Epub ahead of print]

PMID:
31324588
3.

Innovative therapies for neovascular age-related macular degeneration.

Al-Khersan H, Hussain RM, Ciulla TA, Dugel PU.

Expert Opin Pharmacother. 2019 Oct;20(15):1879-1891. doi: 10.1080/14656566.2019.1636031. Epub 2019 Jul 12.

PMID:
31298960
4.

Vascular dysfunction in retinitis pigmentosa.

Lang M, Harris A, Ciulla TA, Siesky B, Patel P, Belamkar A, Mathew S, Verticchio Vercellin AC.

Acta Ophthalmol. 2019 Nov;97(7):660-664. doi: 10.1111/aos.14138. Epub 2019 May 17. Review.

PMID:
31099494
5.

Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States.

Ciulla TA, Huang F, Westby K, Williams DF, Zaveri S, Patel SC.

Ophthalmol Retina. 2018 Jul;2(7):645-653. doi: 10.1016/j.oret.2018.01.006. Epub 2018 Mar 1.

PMID:
31047372
6.

Complement inhibition as a therapeutic strategy in retinal disorders.

Kassa E, Ciulla TA, Hussain RM, Dugel PU.

Expert Opin Biol Ther. 2019 Apr;19(4):335-342. doi: 10.1080/14712598.2019.1575358. Epub 2019 Feb 11.

PMID:
30686077
7.

Stargardt macular dystrophy and evolving therapies.

Hussain RM, Ciulla TA, Berrocal AM, Gregori NZ, Flynn HW Jr, Lam BL.

Expert Opin Biol Ther. 2018 Oct;18(10):1049-1059. doi: 10.1080/14712598.2018.1513486. Epub 2018 Sep 10. Review.

PMID:
30129371
8.

Pharmacotherapy of retinal disease with visual cycle modulators.

Hussain RM, Gregori NZ, Ciulla TA, Lam BL.

Expert Opin Pharmacother. 2018 Apr;19(5):471-481. doi: 10.1080/14656566.2018.1448060. Epub 2018 Mar 15. Review.

PMID:
29542350
9.

Gene therapy for inherited retinal and optic nerve degenerations.

Moore NA, Morral N, Ciulla TA, Bracha P.

Expert Opin Biol Ther. 2018 Jan;18(1):37-49. doi: 10.1080/14712598.2018.1389886. Epub 2017 Oct 23. Review.

PMID:
29057663
10.

Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency.

Hussain RM, Hariprasad SM, Ciulla TA.

Ophthalmic Surg Lasers Imaging Retina. 2017 Oct 1;48(10):780-784. doi: 10.3928/23258160-20170928-01. Review. No abstract available.

PMID:
29020420
11.

The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review.

Bracha P, Moore NA, Ciulla TA, WuDunn D, Cantor LB.

Surv Ophthalmol. 2018 May - Jun;63(3):281-295. doi: 10.1016/j.survophthal.2017.08.008. Epub 2017 Sep 5. Review.

PMID:
28882597
12.

Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration.

Hussain RM, Ciulla TA.

Expert Opin Emerg Drugs. 2017 Sep;22(3):235-246. doi: 10.1080/14728214.2017.1362390. Epub 2017 Aug 4. Review.

PMID:
28756707
13.

Gene therapy for age-related macular degeneration.

Moore NA, Bracha P, Hussain RM, Morral N, Ciulla TA.

Expert Opin Biol Ther. 2017 Oct;17(10):1235-1244. doi: 10.1080/14712598.2017.1356817. Epub 2017 Jul 20. Review.

PMID:
28726562
14.

Induced pluripotent stem cell-based therapy for age-related macular degeneration.

Bracha P, Moore NA, Ciulla TA.

Expert Opin Biol Ther. 2017 Sep;17(9):1113-1126. doi: 10.1080/14712598.2017.1346079. Epub 2017 Jun 30. Review.

15.

Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial.

Jaffe GJ, Ciulla TA, Ciardella AP, Devin F, Dugel PU, Eandi CM, Masonson H, Monés J, Pearlman JA, Quaranta-El Maftouhi M, Ricci F, Westby K, Patel SC.

Ophthalmology. 2017 Feb;124(2):224-234. doi: 10.1016/j.ophtha.2016.10.010. Epub 2016 Oct 28.

PMID:
28029445
16.

Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2016 Apr;123(4):858-64. doi: 10.1016/j.ophtha.2015.11.030. Epub 2016 Jan 8.

17.

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

Ophthalmology. 2016 Mar;123(3):609-16. doi: 10.1016/j.ophtha.2015.10.034. Epub 2015 Dec 8.

18.

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2015 Sep;122(9):1846-53.e5. doi: 10.1016/j.ophtha.2015.05.042. Epub 2015 Jul 2.

19.

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Ciulla TA, Ying GS, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2015 Jun;122(6):1203-11. doi: 10.1016/j.ophtha.2015.02.031. Epub 2015 Mar 29. Erratum in: Ophthalmology. 2015 Aug;122(8):1733. Cuilla, Thomas A [Corrected to Ciulla, Thomas A].

20.

Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Comparison of Age-related Macular Degeneration Treatments Trials CATT Research Group.

Ophthalmology. 2015 Feb;122(2):391-398.e5. doi: 10.1016/j.ophtha.2014.08.020. Epub 2014 Oct 11.

Supplemental Content

Loading ...
Support Center